Ajanta Pharma shares surged by 13.70% to reach a new high of ₹2,540 apiece following a strong performance in Q4 and full fiscal year. The company reported a 66% YoY jump in consolidated net profit in Q4 to ₹122 crore. For the full fiscal year (FY24), the net profit surged to ₹816 crore.